- Home
- GROW vs NNVC Comparison
GROW vs NNVC Comparison
Compare GROW & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROW | NNVC |
|---|---|---|
| Founded | 1968 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 30.6M |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | GROW | NNVC |
|---|---|---|
| Price | $2.94 | $1.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.5K | ★ 316.5K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ 10.00 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $23,850,609.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.23 | $0.85 |
| 52 Week High | $3.65 | $2.23 |
Technical Indicators
Market Signals| Indicator | GROW | NNVC |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 59.32 |
| Support Level | $2.88 | $1.29 |
| Resistance Level | $3.26 | $1.63 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 22.10 | 75.32 |
Price Performance
Historical ComparisonAbout GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.